In the few last years, 3D printing of medical devices has gained worldwide attention; in particular, products such as cranial implants, artificial knees, and spine prostheses, which are personalized for each patient. Such products are marketed under current FDA regulations following their similarities with already existing medical devices. In 2017, the FDA released guidelines for the manufacturing of medical devices and implants; however, there are currently no regulatory guidelines on the 3D printing of other products. In 2015, the FDA released the first 3D printed drug product, Spritam® (levetiracetam). This great technological step led to an increase of research on 3D printing technology to produce drug delivery devices. However, despite the fast development in the field, there are legal and regulatory issues that need to be addressed.
The article cited AMA's "Global 3D Printed Drugs Market Study" explored CAGR of %. According to the report, Increase In Adoption Of Personalized Drugs, And Production Of Combination Medicine
is one of the primary growth factors for the market. High Demand Of Instantaneous Soluble Drugs
is also expected to contribute significantly to the 3D Printed Drugs market. Overall, Personal Use
applications of 3D Printed Drugs, and the growing awareness of them, is what makes this segment of the industry important to its overall growth. The Distribution Channel, such as Medical Stores, is boosting the 3D Printed Drugs market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The End-User, such as Children, is boosting the 3D Printed Drugs market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
AMAs Analyst on the Global 3D Printed Drugs market identified that the demand is rising in many different parts of the world as "Growing Healthcare Infrastructure
The report provides an in-depth analysis and forecast about the industry covering the following key features: o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies o Analyses the Global 3D Printed Drugs market according to Type, Application, and regions o Analyzes the top 10 players in terms of market reach, business strategy, and business focus o Provides stakeholders insights and key drivers & trends of the market
**The market is valued based on weighted average selling price (WASP) and includes any applicable taxes on manufacturers. All currency conversions used in the creation of this report have been calculated using constant annual average 2018 currency rates.
Market Size Estimation In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the 3D Printed Drugs market and other related sub-markets covered in the study.
o Key & emerging players in the market have been observed through secondary research. o The industrys supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes. o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation The overall 3D Printed Drugs market size is calculated using market estimation process, the 3D Printed Drugs market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global 3D Printed Drugs market size has been validated using both top-down and bottom-up approaches.